Page results
-
Information on safer eating during treatment, for patients with blood cancer.
-
This page is intended for patients who suffer from laryngeal dystonia (formerly known as spasmodic dysphonia) who might benefit from this therapy.
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
-
This page answers common questions about high-intensity focused ultrasound (HIFU) treatment for the prostate.
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
-
This page explains what to do and what to avoid when your child has had extractions or minor oral surgery.
-
The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
File results
-
FOI/2024/0303 - Lost histology (histopathology) specimens/ sample tracking systems
-
FOI/2024/0308 - Misuse of Electronic Patient Record systems (EPRS)
-
FOI/2024/0312 - Cleaning brushes and theatre equipment in sterilisation decontamination unit
-
FOI/2024/0317 - Physician associate/ Anaesthesia associate shift hours 2010-2023
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity